Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Propidium is a quaternary ammonium analog of ethidium and functions as an intercalating dye with specific affinity for certain forms of DNA. It is primarily used in research settings as a fluorescent stain to differentiate between viable and non-viable cells by binding to nucleic acids (DNA and RNA). Propidium itself is not membrane-permeant, making it useful for identifying dead or damaged cells with compromised membranes. When used as the diiodide salt (propidium iodide), it exhibits strong fluorescence upon binding to DNA, which allows its application in flow cytometry, microscopy, and cell viability assays. Additionally, propidium can form fluorescent complexes with cholinesterase enzymes and acts as an acetylcholinesterase inhibitor[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on propidium.